Ethylene

Ethylene

SCHEMBL8915548

C=C.CCOC(C)OCC.O=C1CCC(O)CC1

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
SHBG P04278 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL19471886 0.91 LMNA (0.41) LMNA
Ethylene SCHEMBL9049781 0.87 LMNA (0.44) LMNA
Ethylene SCHEMBL140298 0.85 LMNA (0.55) LMNA
SCHEMBL2698061 0.82 LMNA (0.63) LMNA
Cyclohexanone SCHEMBL3835265 0.79 LMNA (0.48) LMNA
Ethylene SCHEMBL8391430 0.79 CYP2D6 (0.36) LMNA
Ethylene SCHEMBL2933706 0.78 ESR2 (0.38)
Ethylene SCHEMBL4424062 0.77 LMNA (0.50) LMNA
Ethylene SCHEMBL5684812 0.77 SHBG (0.41) LMNASHBG
Ethylene SCHEMBL6675160 0.76 LMNA (0.44) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795571-B1 ALKYNYL(HETERO)AROMATIC COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY SHENZHEN TARGETRX INC (CN) 2024-05-08 EP disclosed
US-11840535-B2 Alkynyl(hetero)aromatic compound for inhibiting protein kinase activity SHENZHEN TARGETRX, INC. (CN) 2023-12-12 US disclosed
US-20210284646-A1 ALKYNYL(HETERO)AROMATIC COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY SHENZHEN TARGETRX, INC. (CN) 2021-09-16 US disclosed
EP-3795571-A1 ALKYNYL(HETERO)AROMATIC COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY Shenzhen TargetRx, Inc. (CN) 2021-03-24 EP disclosed
US-5691321-A INSECTICIDES, MITICIDES, PARASITICIDES HOECHST SCHERING AGREVO GMBH (DE) 1997-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210284646-A1 ALKYNYL(HETERO)AROMATIC COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY ALK, BRAF, DSTYK LMNA 2916/4885SHBG 3312/4885
US-11840535-B2 Alkynyl(hetero)aromatic compound for inhibiting protein kinase activity ALK, BRAF, DSTYK LMNA 2916/4885SHBG 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.